United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 3 minute read Pharma Industry News Portage Biotech and Immunova sign LOI for potential iOx Therapeutics acquisition Portage Biotech, Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing innovative therapies to target cancer, has entered into… byPallavi MadhirajuDecember 17, 2024